EDGAR Filing Documents for 0001144204-12-039179

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001144204-12-039179

Filing Date

2012-07-12

Accepted

2012-07-12 15:44:08

Documents

Period of Report

2011-12-31

Filing Date Changed

2012-07-12

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	v317307_10k.htm	10-K	1177120
2	EXHIBIT 31.1	v317307_ex31-1.htm	EX-31.1	9192
3	EXHIBIT 31.2	v317307_ex31-2.htm	EX-31.2	9211
4	EXHIBIT 32.1	v317307_ex32-1.htm	EX-32.1	5598
5	GRAPHIC	pg4.jpg	GRAPHIC	42888
6	GRAPHIC	pg5.jpg	GRAPHIC	121747
	Complete submission text file	0001144204-12-039179.txt		4870957

Data Files

Seq	Description	Document	Type	Size
7	XBRL INSTANCE DOCUMENT	ck0001341293-20111231.xml	EX-101.INS	761983
8	XBRL TAXONOMY EXTENSION SCHEMA	ck0001341293-20111231.xsd	EX-101.SCH	23649
9	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	ck0001341293-20111231_cal.xml	EX-101.CAL	40310
10	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	ck0001341293-20111231_def.xml	EX-101.DEF	137000
11	XBRL TAXONOMY EXTENSION LABEL LINKBASE	ck0001341293-20111231_lab.xml	EX-101.LAB	181269
12	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	ck0001341293-20111231_pre.xml	EX-101.PRE	161962

Mailing Address 445 NORTHERN BLVD STE 24 GREAT NECK NY 11021

Business Address 445 NORTHERN BLVD STE 24 GREAT NECK NY 11021 516-482-1200

Neogenix Oncology Inc (Filer) CIK: 0001341293 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD
Type: 10-K | Act: 34 | File No.: 000-53963 | Film No.: 12959369
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1